phosphatidylcholines has been researched along with Mucocutaneous Lymph Node Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aoyagi, R; Arita, M; Furuno, K; Hamase, K; Hara, T; Hirono, K; Kobayashi, T; Miyamoto, T; Mizuno, Y; Nakashima, Y; Nishio, H; Ohga, S; Onouchi, Y; Sakai, Y; Suzuki, H; Takada, H; Takatsuki, S; Tanabe, K; Tanaka, T; Yamamura, K | 1 |
Chen, X; Chen, XJ; Du, LZ; Li, L; Li, LJ; Lou, JT; Xie, CH; Xu, H; Zhao, ZW | 1 |
2 other study(ies) available for phosphatidylcholines and Mucocutaneous Lymph Node Syndrome
Article | Year |
---|---|
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
Topics: Adaptor Proteins, Signal Transducing; Arteritis; Biomarkers; Case-Control Studies; Child; Child, Preschool; Chromatography, Liquid; Coronary Artery Disease; Female; Humans; Japan; Lipidomics; Lipoproteins, LDL; Male; Mucocutaneous Lymph Node Syndrome; Oxidation-Reduction; Phenylalanine; Phosphatidylcholines; Prospective Studies; Scavenger Receptors, Class E; Tandem Mass Spectrometry | 2021 |
Hypercoagulation and elevation of blood triglycerides are characteristics of Kawasaki disease.
Topics: Bacterial Infections; Blood Coagulation Disorders; Case-Control Studies; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertriglyceridemia; Infant; Lipid Metabolism; Lysophosphatidylcholines; Male; Mucocutaneous Lymph Node Syndrome; Phosphatidylcholines; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Thrombelastography; Triglycerides | 2015 |